HeartBeam Secures FDA Clearance for Cable-free ECG Platform, Earns Industry Recognitions
HeartBeam achieved FDA clearance for its cable-free, high-fidelity HeartBeam System, which captures cardiac electrical signals from three directions to synthesize a 12-lead ECG for arrhythmia assessment. It was spotlighted in an industry milestone roundup and included in PatentVest's Total Cardiac Intelligence report, underscoring regulatory momentum.
1. Industry Milestone Roundup Recognition
HeartBeam was featured in an industry milestone roundup highlighting companies that achieved recent FDA clearances, underscoring its regulatory progress in cardiac diagnostics.
2. HeartBeam System Technology
The HeartBeam System is a cable-free, high-fidelity ECG platform capturing cardiac electrical signals from three spatial directions to synthesize a diagnostic-quality 12-lead ECG for arrhythmia assessment, aiming to simplify remote cardiac monitoring.
3. PatentVest Total Cardiac Intelligence Inclusion
The company also gained inclusion in PatentVest's Total Cardiac Intelligence report, which profiles firms demonstrating forward momentum in cardiac diagnostics, highlighting HeartBeam’s alignment with patent and clinical priorities.